Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.

[1]  J. Burke,et al.  Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. , 2021, The New England journal of medicine.

[2]  S. Culine,et al.  Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial. , 2021, European urology.

[3]  B. Trock,et al.  Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma. , 2021, European urology oncology.

[4]  U. Capitanio,et al.  The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. , 2020, European urology oncology.

[5]  M. Kattan,et al.  Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. , 2020, Urologic oncology.

[6]  K. Bensalah,et al.  Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge? , 2020, European urology.

[7]  J. Brugarolas,et al.  Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma. , 2019, Urologic oncology.

[8]  J. Wolchok,et al.  Cancer immunotherapy using checkpoint blockade , 2018, Science.

[9]  Arivazhagan Selvaraj,et al.  Texture classification using Gabor wavelets based rotation invariant features , 2006, Pattern Recognit. Lett..

[10]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..